Immune activation in the female genital tract: Expression profiles of soluble proteins in women at high risk for HIV infection

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Francis, Suzanna C ^a,b   Hou, Yanwen ^c   Baisley, Kathy ^a   Van De Wijgert, Janneke ^d   Watson Jones, Deborah ^a,b   Ao, Trong T ^a,b   Herrera, Carolina ^e   Maganja, Kaballa ^b   Andreasen, Aura ^a,b   Kapiga, Saidi ^a,b   Coulton, Gary R ^c   Hayes, Richard J ^a   Shattock, Robin J ^e  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b National Institute for Medical Research   (Tanzania)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 3; BETA DEFENSIN 4; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MEDROXYPROGESTERONE ACETATE; MONOCYTE CHEMOTACTIC PROTEIN 1; ORAL CONTRACEPTIVE AGENT; PROSTATE SPECIFIC ANTIGEN; PROTEIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; ANILINE DERIVATIVE; CYTOKINE; IMMUNOGLOBULIN; N,N-DIMETHYL-4-ANISIDINE; RNA 16S;

ADAPTIVE IMMUNITY; ADULT; ANTIGEN DETECTION; ARTICLE; CERVICOVAGINAL LAVAGE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FEMALE GENITAL SYSTEM; HIGH RISK PATIENT; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INNATE IMMUNITY; LONGITUDINAL STUDY; OVULATION; PROTEIN EXPRESSION; RISK ASSESSMENT; SEMINAL PLASMA; SEXUAL INTERCOURSE; TANZANIA; VAGINA PH; VAGINAL LAVAGE; ADOLESCENT; CHEMISTRY; CYTOLOGY; DEMOGRAPHY; GENETICS; HIV INFECTIONS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEUKOCYTE; MENSTRUAL CYCLE; METABOLISM; MICROBIOLOGY; NEISSERIA GONORRHOEAE; PH; REPRODUCTIVE TRACT INFECTIONS; RISK; SIMPLEXVIRUS; VAGINA; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANILINE COMPOUNDS; CONTRACEPTIVES, ORAL, HORMONAL; CYTOKINES; DEMOGRAPHY; FEMALE; HEMOGLOBINS; HIV INFECTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULINS; LEUKOCYTES; MENSTRUAL CYCLE; NEISSERIA GONORRHOEAE; PROSTATE-SPECIFIC ANTIGEN; REPRODUCTIVE TRACT INFECTIONS; RISK; RNA, RIBOSOMAL, 16S; SIMPLEXVIRUS; VAGINA; VAGINAL DOUCHING; YOUNG ADULT;

EID: 84958191475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143109     Document Type: Article

References (59)

1. UN Joint Programme on HIV/AIDS. Global Epidemic: UNAIDS Report on the Global AIDS Epidemic: 2012 [Internet]. Geneva; 2012. Available: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120-UNAIDS-Global-Report-2012-en. pdf
2. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (80-). 2010/07/21 ed. 2010;329:1168-1174. [pii] doi: 10.1126/science.1193748
3. Souza M De, Adams E, Benenson M, Gurunathan S, Tartaglia J, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361:2209-20. doi: 10.1056/NEJMoa0908492 PMID: 19843557
4. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587-99. doi: 10. 1056/NEJMoa1011205 PMID: 21091279
5. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana. N Engl J Med. 2012;120711140017009. doi: 10.1056/NEJMoa1110711
6. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. N Engl J Med. 2012;120711140017009. doi: 10. 1056/NEJMoa1108524
7. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. Elsevier Ltd; 2013;381:2083-90. doi: 10.1016/S0140-6736 (13) 61127-7 PMID: 23769234
8. Fichorova RN, Tucker LD, Anderson DJ. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis. 2001/07/27 ed. 2001;184:418-428. doi: JID010196 [pii] doi: 10.1086/322047 PMID: 11471099
9. Mesquita PM, Cheshenko N, Wilson SS, Mhatre M, Guzman EM, Fakioglu E, et al. Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety. J Infect Dis. 2009/07/10 ed. 2009;200:599-608. doi: 10.1086/600867 PMID: 19586414
10. Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, et al. Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study). J Infect Dis. 2012;206:258-66. doi: 10.1093/infdis/jis342 PMID: 22561365
11. Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature. Nature Publishing Group; 2010;464:217-23. doi: 10.1038/nature08757 PMID: 20220840
12. Cummins JE, Doncel GF. Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety. Sex Transm Dis. 2009;36:S84-91. doi: 10.1097/OLQ.0b013e3181994191 PMID: 19218890
13. Fichorova RN. Guiding the vaginal microbicide trials with biomarkers of inflammation. J Acquir Immune Defic Syndr. 2004;37 Suppl 3:S184-93. Available: http://www.pubmedcentral.nih.gov/articlerender. fcgi?artid=2643374&tool=pmcentrez&rendertype=abstract PMID: 16419271
14. Keller MJ, Guzman E, Hazrati E, Kasowitz A, Cheshenko N, Wallenstein S, et al. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS. 2007;21:467-76. doi: 10.1097/QAD.0b013e328013d9b5 PMID: 17301565
15. Bollen LJM, Blanchard K, Kilmarx PH, Chaikummao S, Connolly C, Wasinrapee P, et al. No increase in cervicovaginal proinflammatory cytokines after Carraguard use in a placebo-controlled randomized clinical trial. J Acquir Immune Defic Syndr. 2008;47:253-7. doi: 10.1097/QAI.0b013e31815d2f12 PMID: 18025996
16. Moscicki A, Kaul R, Ma Y, Scott ME, Daud II, Bukusi EA, et al. Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety. J Acquir Immune Defic Syndr. 2012;59:134-40. doi: 10.1097/QAI.0b013e31823f2aeb PMID: 22067666
17. Schwartz JL, Mauck C, Lai J-J, Creinin MD, Brache V, Ballagh SA, et al. Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study. Contraception. 2006;74:133-40. doi: 10.1016/j.contraception. 2006.02.008 PMID: 16860051
18. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet. 2008;372:1881-93. doi: 10.1016/S0140-6736 (08) 61591-3 PMID: 19012954
19. Gray GE, Allen M, Moodie Z, Churchyard G, Bekker L-G, Nchabeleng M, et al. Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect Dis. 2011;11:507-15. doi: 10. 1016/S1473-3099 (11) 70098-6 PMID: 21570355
20. Fichorova RN, Lai J, Schwartz JL, Weiner DH, Mauck CK, Callahan MM. Baseline variation and associations between subject characteristics and five cytokine biomarkers of vaginal safety among healthy non-pregnant women in microbicide trials. Cytokine. Elsevier Ltd; 2011;55:134-40. doi: 10.1016/j. cyto.2011.03.016 PMID: 21530305
21. Kyongo JK, Jespers V, Goovaerts O, Michiels J, Menten J, Fichorova RN, et al. Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy caucasian women. PLoS One. 2012;7:e43951. doi: 10.1371/journal.pone.0043951 PMID: 22952818
22. Kyongo JK, Crucitti T, Menten J, Hardy L, Cools P, Michiels J, et al. A cross-sectional analysis of selected genital tract immunological markers and molecular vaginal microbiota in Sub-Saharan African women with relevance to HIV risk and prevention. Clin Vaccine Immunol. 2015;22:CVI.00762-14. doi: 10.1128/CVI.00762-14
23. Al-Harthi L, Kovacs a, Coombs RW, Reichelderfer PS, Wright DJ, Cohen MH, et al. A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding. AIDS. 2001;15:1535-43. Available: http://www.ncbi.nlm.nih.gov/pubmed/11504986 PMID: 11504986
24. Al-Harthi L, Wright DJ, Anderson D, Cohen M, Matity Ahu D, Cohn J, et al. The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments. J Interferon Cytokine Res. 2000;20:719-24. doi: 10.1089/10799900050116426 PMID: 10954915
25. Huijbregts RPH, Helton ES, Michel KG, Sabbaj S, Richter HE, Goepfert PA, et al. Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms. Endocrinology. 2013;154:1282-95. doi: 10.1210/en. 2012-1850 PMID: 23354099
26. Sharkey DJ, Tremellen KP, Jasper MJ, Gemzell-Danielsson K, Robertson SA. Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol. 2012;188:2445-54. doi: 10.4049/jimmunol.1102736 PMID: 22271649
27. Rebbapragada A, Howe K, Wachihi C, Pettengell C, Sunderji S, Huibner S, et al. Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr. 2008/11/08 ed. 2008;49:520-2. doi: 10.1097/QAI.0b013e318189a7ca PMID: 18989228
28. Fichorova RN, Desai PJ, Gibson FC, Genco CA. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect Immun. 2001;69:5840-8. doi: 10.1128/IAI.69.9.5840 PMID: 11500462
29. Fichorova RN. Impact of T. vaginalis infection on innate immune responses and reproductive outcome. J Reprod Immunol. 2009;83:185-9. doi: 10.1016/j.jri.2009.08.007 PMID: 19850356
30. Rebbapragada A, Wachihi C, Pettengell C, Sunderji S, Huibner S, Jaoko WG, et al. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS. 2007;21:589-98. doi: 10.1097/QAD.0b013e328012b896 PMID: 17314521
31. Hilber AM, Chersich MF, van de Wijgert J HHM, Rees H, Temmerman M. Vaginal practices, microbicides and HIV: what do we need to know? Sex Transm Infect. 2007/11/21 ed. 2007;83:505-508. doi: 10.1136/sti.2007.028597 PMID: 18024709
32. Kapiga SH, Ewings FM, Ao TT, Chilongani J, Mongi A, Baisley K, et al. The Epidemiology of HIV and HSV-2 Infections among Women Participating in Microbicide and Vaccine Feasibility Studies in Northern Tanzania. PLoS One. 2013;8:e68825. doi: 10.1371/journal.pone.0068825 PMID: 23874780
33. McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, doubleblind, parallel-group trial. Lancet. 2010/09/21 ed. 2010;376:1329-37. doi: 10.1016/S0140-6736 (10) 61086-0 PMID: 20851460
34. Watson-Jones D, Weiss HA, Rusizoka M, Changalucha JM, Baisley K, Mugeye KK, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med. 2008/03/14 ed. 2008;358:1560-71. doi: 10.1056/NEJMoa0800260 PMID: 18337596
35. Macaluso M, Lawson L, Akins R a, Valappil T, Hammond KR, Blackwell R, et al. Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure. Contraception. 1999;59:195-201. Available: http://www.ncbi.nlm.nih.gov/pubmed/10382083 PMID: 10382083
36. Christine Mauck. Manual for the Standardization of Colposcopy for the Evaluation of Vaginal Products [Internet]. 2004. Available: http://www.conrad.org/assets/attachments/Revised-Manual. PDF
37. Doyle AM, Ross DA, Maganja K, Baisley K, Masesa C, Andreasen A, et al. Long-term biological and behavioural impact of an adolescent sexual health intervention in Tanzania: follow-up survey of the community-based MEMA kwa Vijana Trial. PLoS Med. 2010;7:e1000287. doi: 10.1371/journal.pmed. 1000287 PMID: 20543994
38. Nugent RP, Krohn MA, Hillier SL, Vaginosis B. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297-301. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=269757&tool=pmcentrez&rendertype=abstract PMID: 1706728
39. Hochmeister MN, Budowle B, Rudin O, Gehrig C, Borer U, Thali M, et al. Evaluation of prostate-specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid. J Forensic Sci. 1999;44:1057-60. Available: http://www.ncbi.nlm.nih.gov/pubmed/10486959 PMID: 10486959
40. Biancotto A, Grivel J-C, Iglehart SJ, Vanpouille C, Lisco A, Sieg SF, et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood. 2007;109:4272-9. doi: 10.1182/blood-2006-11-055764 PMID: 17289812
41. Fischetti L, Barry SM, Hope TJ, Shattock RJ. HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS. 2009;23:319-28. doi: 10.1097/QAD.0b013e328321b778 PMID: 19114867
42. Kassam A, Overstreet JW, Snow-Harter C, De Souza MJ, Gold EB, Lasley BL. Identification of Anovulation and Transient Luteal Function Using a Urinary Pregnanediol-3-Glucuronide Ratio Algorithm. Environ Health Perspect. 1996;104:408-413. PMID: 8732951
43. O'Connor K a, Brindle E, Miller RC, Shofer JB, Ferrell RJ, Klein N a, et al. Ovulation detection methods for urinary hormones: precision, daily and intermittent sampling and a combined hierarchical method. Hum Reprod. 2006;21:1442-52. doi: 10.1093/humrep/dei497 PMID: 16439502
44. United Nations. World Contraceptive Patterns 2013. United Nations, New York. 2013;11-12. doi: 10. 1016/S0140
45. Morrison CS, Chen P-L, Kwok C, Baeten JM, Brown J, Crook AM, et al. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med. 2015;12:e1001778. doi: 10.1371/journal.pmed.1001778 PMID: 25612136
46. Morrison C, Fichorova R, Mauck C, Chen P, Kwok C, Chipato T, et al. Cervical Inflammation and Immunity Associated with Hormonal Contraception, Pregnancy and HIV-1 Seroconversion. J Acquir Immune Defic Syndr. 2014; doi: 10.1097/QAI.0000000000000103
47. Deese J, Masson L, Miller W, Cohen M, Morrison C, Wang M, et al. Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract. Am J Reprod Immunol. 2015; n/a-n/a. doi: 10.1111/aji.12415
48. Usala SJ, Usala FO, Haciski R, Holt JA, Schumacher GF. IgG and IgA content of vaginal fluid during the menstrual cycle. J Reprod Med. 1989;34:292-4. Available: http://www.ncbi.nlm.nih.gov/pubmed/2715991 PMID: 2715991
49. Lü FX, Ma Z, Rourke T, Srinivasan S, McChesney M, Miller CJ. Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle. Infect Immun. 1999;67:6321-8. Available: http://www.pubmedcentral. nih.gov/articlerender.fcgi?artid=97036&tool=pmcentrez&rendertype=abstract PMID: 10569744
50. Wira CR, Rodriguez-Garcia M, Shen Z, Patel M, Fahey JV. The role of sex hormones and the tissue environment in immune protection against HIV in the female reproductive tract. American Journal of Reproductive Immunology. 2014. pp. 171-181. doi: 10.1111/aji.12235 PMID: 24661500
51. Chandra N, Thurman AR, Anderson S, Cunningham TD, Yousefieh N, Mauck C, et al. Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues. AIDS Res Hum Retroviruses. 2013;29:592-601. doi: 10.1089/aid.2012.0271 PMID: 23189932
52. Robertson SA. Seminal plasma and male factor signalling in the female reproductive tract. Cell Tissue Res. 2005;322:43-52. doi: 10.1007/s00441-005-1127-3 PMID: 15909166
53. Norvell MK, Benrubi GI, Thompson RJ. Investigation of microtrauma after sexual intercourse. J Reprod Med. 1984;29:269-71. Available: http://www.ncbi.nlm.nih.gov/pubmed/6716372 PMID: 6716372
54. Hwang LY, Scott ME, Ma Y, Moscicki A-B. Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium. J Reprod Immunol. 2011;88:66-71. doi: 10.1016/j.jri.2010.07.008 PMID: 21051089
55. Bright PL, Norris Turner A, Morrison CS, Wong EL, Kwok C, Yacobson I, et al. Hormonal contraception and area of cervical ectopy: a longitudinal assessment. Contraception. Elsevier Inc.; 2011;84:512-9. doi: 10.1016/j.contraception. 2011.02.002 PMID: 22018127
56. Hilber AM, Francis SC, Chersich MF, Scott P, Redmond S, Bender N, et al. Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis. PLoS One. 2010/02/18 ed. 2010;5:e9119. doi: 10.1371/journal.pone.0009119 PMID: 20161749
57. Low N, Chersich MF, Schmidlin K, Egger M, Francis SC, van de Wijgert J HHM, et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med. 2011 Feb. 1. 2011;8:e1000416. doi: 10.1371/journal.pmed.1000416 PMID: 21358808
58. Francis SC, Baisley K, Lees SS, Andrew B, Zalwango F, Seeley J, et al. Vaginal Practices among Women at High Risk of HIV Infection in Uganda and Tanzania: Recorded Behaviour from a Daily Pictorial Diary. Thorne C, editor. PLoS One. 2013;8:e59085. doi: 10.1371/journal.pone.0059085 PMID: 23555618
59. Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med. 2009;15:886-92. doi: 10.1038/nm.2006 PMID: 19648930